<DOC>
	<DOC>NCT00902460</DOC>
	<brief_summary>CP-690,550 and midazolam are metabolized by similar enzymes in the liver. This study is designed to assess whether co-administration of CP-690,500 and midazolam will effect the metabolism of midazolam in healthy volunteers.</brief_summary>
	<brief_title>CP-690,550 and Midazolam Drug-Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy male and/or female (nonchild bearing potential) subjects Clinically significant infections within the past 3 months History of previously untreated infection with Mycobacterium tuberculosis Positive screening test for hepatitis B surface antigen, antihepatitis C antibody, or human immunodeficiency virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents</keyword>
</DOC>